Phathom Pharmaceuticals (PHAT) Reiterated at Overweight at Cantor Fitzgerald Jan 14, 2026 06:59AM
Phathom Pharmaceuticals prices $130 million stock offering Jan 7, 2026 10:33PM
Phathom Pharmaceuticals prices $130 million public offering Jan 7, 2026 10:33PM
Phathom Pharmaceuticals Announces Pricing of $130 Million Public Offering of Common Stock and Pre-Funded Warrants Jan 7, 2026 10:33PM
Phathom Pharmaceuticals Announces Pricing of $130 Million Public Offering of Common Stock and Pre-Funded Warrants Jan 7, 2026 10:33PM


Jan 7, 2026 04:05PM Phathom Pharmaceuticals announces public stock offering
Jan 7, 2026 04:05PM Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Oct 15, 2025 06:59AM Cantor Fitzgerald Says Phathom Pharmaceuticals (PHAT) is Top Pick After Focusing on GI
Oct 9, 2025 07:13AM Cantor Fitzgerald Reiterates Overweight Rating on Phathom Pharmaceuticals (PHAT)
Jun 6, 2025 01:16PM Phathom Pharmaceuticals (PHAT) PT Raised to $29 at Cantor Fitzgerald